CHM Infection Expert Advisory GroupNHS
Job summary
Please note that applications submitted to [email protected] will be considered only.
The Commission on Human Medicines (CHM) is looking to appoint one expert to the Infection Expert Advisory Group (IEAG). The Medicines and Healthcare products Regulatory Agency enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research. The IEAG is an independent advisory committee of the CHM that provide impartial advice to Ministers on the safety and efficacy of medicines for use in infections including HIV, AIDS and viral hepatitis. The IEAG membership includes a wide range of highly skilled professionals who are senior and well regarded in their respective fields and lay representatives.
Main duties of the job
The Member must be able to demonstrate the qualities, skills and experience to meet all the essential criteria for appointment. Ideally, experience in management and functional cure of viral hepatitis from an ID/Virology background.
Job description
The Member must be able to demonstrate the qualities, skills and experience to meet all the essential criteria for appointment. Ideally, experience in management and functional cure of viral hepatitis from an ID/Virology background.
Expertise Required:
Specialist in Viral Hepatitis
Additional expertise in HIV medicine (or any other ID sub-specialty), in viral therapeutics or immunotherapy or in global health issues related to viral hepatitis would be encouraged, but is not essential.
To make an application please email your application form, CV, completed monitoring form and declaration of interest form to: [email protected], quoting the position and reference IEAG26-1 in the subject field.
Please note that applications submitted to [email protected] will be considered only.
About us
The Medicines and Healthcare products Regulatory Agency (MHRA) enhance and improve the health of millions of people every day through the effective regulation of medicines and medical devices, underpinned by science and research.
The Commission on Human Medicines (CHM) advises Ministers on the safety, efficacy and quality of medicines. The CHM is an advisory non-departmental public body sponsored by the Department of Health and Social Care. The MHRA provides administrative support in its role as secretariat to the CHM.
The Infection Expert Advisory Group (IEAG) is an independent advisory committee of the CHM that provides impartial advice to Ministers on the safety and efficacy of medicines for use in infections including HIV, AIDS and viral hepatitis. The IEAG membership includes a wide range of highly skilled professionals who are senior and well regarded in their respective fields and lay representatives.
The MHRA values and promotes diversity and encourages applications from all sections of the community.